Zobrazeno 1 - 10
of 150
pro vyhledávání: '"Sabra K"'
Autor:
Ashley A. Adile, Michelle M. Kameda-Smith, David Bakhshinyan, Laura Banfield, Sabra K. Salim, Forough Farrokhyar, Adam J. Fleming
Publikováno v:
Systematic Reviews, Vol 9, Iss 1, Pp 1-9 (2020)
Abstract Background Central nervous system tumors remain the leading cause of cancer-related mortality amongst children with solid tumors, with medulloblastoma (MB) representing the most common pediatric brain malignancy. Despite best current therapi
Externí odkaz:
https://doaj.org/article/34293094f61d4862ae0face0faf10346
Publikováno v:
STAR Protocols, Vol 2, Iss 4, Pp 100920- (2021)
Summary: Advances in chimeric antigen receptor (CAR) T cell therapies have led to the modality dominating translational cancer research; however, a standardized protocol for evaluating such therapies in vitro is needed. This protocol details the in v
Externí odkaz:
https://doaj.org/article/ef405b1b714549da8142d2fdec868794
Publikováno v:
STAR Protocols, Vol 1, Iss 3, Pp 100124- (2020)
Summary: Despite a surge in the preclinical development of immunotherapies, current models are unable to predict putative toxicity, particularly the “on-target, off-tumor” effects of these therapeutics. To address this gap, we used a humanized mo
Externí odkaz:
https://doaj.org/article/739c67f503184112b8019c3dbee72bab
Autor:
Nazanin Tatari, William T. Maich, Sabra K. Salim, Dillon Mckenna, Chitra Venugopal, Sheila Singh
Publikováno v:
STAR Protocols, Vol 1, Iss 3, Pp 100174- (2020)
Summary: Glioblastoma (GBM) is the most common malignant adult brain tumor that is resistant to the standard care therapy. Advances in chimeric antigen receptor (CAR) T cell therapies have spurred renewed interest in developing CAR T cell therapies t
Externí odkaz:
https://doaj.org/article/915efde6842243eb88b230ca0e0e28fc
Autor:
Qazi, Maleeha A., Salim, Sabra K., Brown, Kevin R., Mikolajewicz, Nicholas, Savage, Neil, Han, Hong, Subapanditha, Minomi K., Bakhshinyan, David, Nixon, Allison, Vora, Parvez, Desmond, Kimberly, Chokshi, Chirayu, Singh, Mohini, Khoo, Amanda, Macklin, Andrew, Khan, Shahbaz, Tatari, Nazanin, Winegarden, Neil, Richards, Laura, Pugh, Trevor, Bock, Nicholas, Mansouri, Alireza, Venugopal, Chitra, Kislinger, Thomas, Goyal, Sidhartha, Moffat, Jason, Singh, Sheila K.
Publikováno v:
In Cell Reports 27 September 2022 40(13)
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Annals of Allergy, Asthma & Immunology. 129:122-124
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c6f58acd26733e44e8320e73c751f833
https://doi.org/10.1016/j.anai.2022.04.010
https://doi.org/10.1016/j.anai.2022.04.010
Publikováno v:
In Annals of Allergy, Asthma & Immunology July 2022 129(1):122-124
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Maleeha A. Qazi, Sabra K. Salim, Kevin R. Brown, Nicholas Mickolajewicz, Neil Savage, Hong Han, Minomi K. Subapanditha, David Bakhshinyan, Allison Nixon, Parvez Vora, Kimberly Desmond, Chirayu Chokshi, Mohini Singh, Amanda Khoo, Andrew Macklin, Shahbaz Khan, Nazanin Tatari, Neil Winegarden, Laura Richards, Trevor Pugh, Nicholas Bock, Alireza Mansouri, Chitra Venugopal, Thomas Kislinger, Sidhartha Goyal, Jason Moffat, Sheila K. Singh
Recurrence of solid tumors renders patients vulnerable to a distinctly advanced, highly treatment-refractory disease state that has an increased mutational burden and novel oncogenic drivers not detected at initial diagnosis. Improving outcomes for r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c62df87b1d6390de6e92ab2712bf8202
https://doi.org/10.1101/2022.01.28.478232
https://doi.org/10.1101/2022.01.28.478232
